Loading
  • Cortisol Modulation
  • Stories
  • Careers
  • Contact
  • Home
  • About
    • Our Team
  • Products
    • Medical Information Request
  • Science
    • Pipeline and Clinical Trials
    • Cortisol Modulation
    • Therapeutic Areas
    • Publications
    • Investigator Initiated Studies
  • Resources
    • Grants
    • Compassionate use
    • State Required Notice
  • Investors
    • Overview
    • Press Releases
    • Events
    • Corporate Governance
    • Analyst Coverage
    • Stock Information
    • SEC Filings
  • Search
  • Menu Menu
  • Home
  • About
    • Teams
  • Products
    • Medical Information Request
  • Science
    • Pipeline and Clinical Trials
    • Cortisol Modulation
    • Therapeutic Areas
    • Publications
    • Investigator Initiated Studies
  • Resources
    • Grants
    • Compassionate use
    • State Required Notice
  • Stories
  • Careers
  • Contact
  • Investors
    • Overview
    • Press Releases
    • Events
    • Corporate Governance
    • Analyst Coverage
    • Stock Information
    • SEC Filings
  • Privacy Notice
  • Terms of Use
  • Site Map

About jeremiah@devisedesigns.com

This author has not written his bio yet.
But we are proud to say that jeremiah@devisedesigns.com contributed 151 entries already.

Entries by jeremiah@devisedesigns.com

Oncology

Selective Glucocorticoid Receptor Modulators (SGRMs) delay castrate-resistant prostate cancer growth.

Kach et al. • 2017 • Mol Cancer Ther. 2017;16(8):1680-1692.

October 18, 2018
Metabolism

Selective glucocorticoid receptor antagonist CORT125281 activates brown adipose tissue and alters lipid distribution in male mice.

Kroon et al. • 2017 • Endocrinology. 2017 Sep 18. doi:10.1210/en.2017-00512.

September 19, 2018
Metabolism

A novel combined glucocorticoid-mineralocorticoid receptor selective modulator markedly prevents weight gain and fat mass expansion in mice fed a high-fat diet.

Mammi et al. • 2016 • Int J Obes (Lond). 2016;40(6):964-72.

September 19, 2018
Metabolism

Identification of a selective glucocorticoid receptor modulator that prevents both diet-induced obesity and inflammation.

van den Heuvel et al. • 2016 • Br J Pharmacol. 2016;173(11):1793-804.

September 19, 2018
Metabolism

Glucocorticoid antagonism limits adiposity rebound and glucose intolerance in young male rats following the cessation of daily exercise and caloric restriction.

Teich et al. • 2016 • Am J Physiol Endocrinol Metab. 2016;311(1):E56-68.

September 19, 2018
Metabolism

Effects of selective and non-selective glucocorticoid receptor II antagonists on rapid-onset diabetes in young rats.

Beaudry et al. • 2014 • PLoS One. 2014;9(3):e91248.

September 19, 2018
Metabolism

Discovery of a novel non-steroidal GR antagonist with in vivo efficacy in the olanzapine-induced weight gain model in the rat.

Hunt et al. • 2012 • Bioorg Med Chem Lett. 2012;22(24):7376-80.

September 19, 2018
Metabolism

Selective glucocorticoid receptor (GR-II) antagonist reduces body weight gain in mice.

Asagami et al. • 2011 • J Nutr Metab. 2011;2011:235389.

September 19, 2018
Metabolism

Selective glucocorticoid receptor (type II) antagonists prevent weight gain caused by olanzapine in rats.

Belanoff et al. • 2011 • Eur J Pharmacol. 2011;655(1-3):117-20.

September 19, 2018
Metabolism

The efficacy of mifepristone in the reduction and prevention of olanzapine-induced weight gain in rats.

Beebe et al. • 2006 • Behav Brain Res. 2006;171(2):225-9.

September 19, 2018
Page 10 of 16«‹89101112›»

Categories

  • Endocrinology
  • Hypercortisolism (Cushing syndrome)
  • Metabolism
  • Neurology
  • Oncology
  • Other
  • Uncategorized

© 2024 Corcept Therapeutics, Incorporated

Privacy Notice | Terms of Use | Site Map | Your Privacy Choices | LinkedIn | Youtube

Privacy Notice

Terms of Use

Site Map

Your Privacy Choices

LinkedIn

Youtube

Scroll to top